We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

172 hedge funds and large institutions have $734M invested in Collegium Pharmaceutical in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 63 increasing their positions, 55 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 14

45% more call options, than puts

Call options by funds: $719K | Put options by funds: $497K

15% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 55

10% more capital invested

Capital invested by funds: $668M → $734M (+$65.6M)

8% more funds holding

Funds holding: 159 → 172 (+13)

4.47% more ownership

Funds ownership: 103.63% → 108.09% (+4.5%)

Holders
172
Holders Change
+13
Holders Change %
+8.18%
% of All Funds
2.71%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
29
Increased
63
Reduced
55
Closed
14
Calls
$719K
Puts
$497K
Net Calls
+$222K
Net Calls Change
+$205K

Top Buyers

1
RCMNY
Rubric Capital Management (New York)
New York
+$7.43M
2
DZ Bank
DZ Bank
Germany
+$5.09M
3
EA
Emerald Advisers
Pennsylvania
+$4.26M
4
Morgan Stanley
Morgan Stanley
New York
+$3.24M
5
State Street
State Street
Massachusetts
+$3.12M

Top Sellers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$26.8M
2
RHJA
Rice Hall James & Associates
California
-$5.04M
3
JG
Jefferies Group
New York
-$3.01M
4
SDIC
South Dakota Investment Council
South Dakota
-$1.42M
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$1.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$116M +$1.62M +85,645 +2%
RCMNY
2
Rubric Capital Management (New York)
New York
$61.1M +$7.43M +393,500 +15%
EAM
3
Eventide Asset Management
Massachusetts
$53.5M – – –
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$48M -$26.8M -1,417,521 -38%
Vanguard Group
5
Vanguard Group
Pennsylvania
$47M +$361K +19,112 +0.8%
Principal Financial Group
6
Principal Financial Group
Iowa
$28.9M +$2.11M +111,770 +9%
State Street
7
State Street
Massachusetts
$26.6M +$3.12M +165,144 +14%
Renaissance Technologies
8
Renaissance Technologies
New York
$25.9M +$261K +13,800 +1%
CCM
9
Camber Capital Management
Massachusetts
$21.4M – – –
Invesco
10
Invesco
Georgia
$20.6M +$210K +11,090 +1%
Massachusetts Financial Services
11
Massachusetts Financial Services
Massachusetts
$17.6M +$423K +22,401 +3%
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$17.3M +$951K +50,351 +6%
EA
13
Emerald Advisers
Pennsylvania
$16.3M +$4.26M +225,281 +39%
RSCM
14
Rock Springs Capital Management
Maryland
$14.8M – – –
EMFAT
15
Emerald Mutual Fund Advisers Trust
Pennsylvania
$13.6M +$345K +18,281 +3%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$12.4M +$103K +5,468 +0.9%
PCM
17
Peregrine Capital Management
Minnesota
$11.3M -$364K -19,241 -3%
RHJA
18
Rice Hall James & Associates
California
$8.9M -$5.04M -267,001 -38%
Northern Trust
19
Northern Trust
Illinois
$7.99M -$278K -14,704 -4%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$7.89M -$206K -10,880 -3%
Morgan Stanley
21
Morgan Stanley
New York
$7.44M +$3.24M +171,706 +89%
LSV Asset Management
22
LSV Asset Management
Illinois
$7.33M -$34K -1,800 -0.5%
RA
23
Royce & Associates
New York
$5.93M -$617K -32,632 -10%
Ameriprise
24
Ameriprise
Minnesota
$5.92M +$413K +21,878 +8%
DZ Bank
25
DZ Bank
Germany
$5.48M +$5.09M +269,351 New
1
2 3 4 5

COLL Hedge Fund Activity: Q1 2022 in Review

172 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q1 2022, worth a combined $734M — up 9.8% from $668M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new COLL positions and 14 closed out — a net gain of 15 holders — while 63 added to existing stakes and 55 trimmed.

The largest buyer was Rubric Capital Management (New York), adding an estimated $7.43M. The largest seller was Janus Henderson Group, cutting an estimated $26.8M.

  • 172 institutional investors held Collegium Pharmaceutical (COLL) as of Q1 2022, up from 159 in Q4 2021.
  • Funds reported $734M of Collegium Pharmaceutical stock for Q1 2022, up 9.8% quarter-over-quarter.
  • 29 funds opened new Collegium Pharmaceutical positions in Q1 2022 and 14 closed out, a net change of +15 holders.
  • The largest Collegium Pharmaceutical buyer in Q1 2022 was Rubric Capital Management (New York), an estimated $7.43M added.
  • The largest Collegium Pharmaceutical seller in Q1 2022 was Janus Henderson Group, an estimated $26.8M sold.

Based on aggregated 13F filings for Q1 2022.